Michael ANDESRON

Bio :

Michael is a National Institute for Health Research (NIHR) funded Clinical Lecturer (Assistant Professor) within the Centre for Primary Care & Health Services Research at the University of Manchester, and Senior Visiting Fellow at the Department of Health Policy, London School of Economics and Political Science (LSE). He is an associate editor at Health Economics, Policy and Law (HEPL). He is focused on producing high-impact research concentrated on five key areas:

(1)   measures of healthcare quality

(2)   the public-private interface in healthcare

(3)   workforce planning and strategy

(4)   disinvestment in low-value care

(5)   pharmaceutical policy (including antimicrobial resistance)

Throughout all his work, Michael endeavours to take an international perspective to compare and contrast how health systems are organised, financed, and delivered and potential implications for health system performance. This is evidenced by work as co-research lead for the 2021 LSE-Lancet Commission on “The Future of the NHS”, the 2021 England Partnership for Health System Sustainability and Resilience (PHSSR) report, and as lead author of the 2022 UK Health System in Transition report for the European Observatory on Health Systems and Policies (EOHSP). Michael has also been awarded a post on the 2025 Science Po Laboratory for Interdisciplinary Evaluation of Public Policies (LIEEP) International Scholars in Policy Evaluation programme. Michael remains committed to working with policymakers to promote evidence-based policy design and implementation. At the international level, this includes experience working as a technical advisor to World Health Organisation (WHO) Geneva office, WHO EURO office, and for the 2019 Romanian, 2023 Swedish, and 2024 Belgian Presidencies of the EU Council. At the national level, this includes fellowships with NHS England to evaluate the NHS Evidence Based Interventions (EBI) to programme, and with the UK Private Healthcare Information Network (PHIN) on strategies to improve reporting of activity and quality in the private healthcare sector. He also brings clinical experience and insights to his research as he continues to practice as a general practitioner.